Current neuroimaging techniques have very limited abilities to directly identify and quantify neurotransmitters from brain sections. We have developed a molecular-specific approach for the simultaneous imaging and quantitation of multiple neurotransmitters, precursors, and metabolites, such as tyrosine, tryptamine, tyramine, phenethylamine, dopamine, 3-methoxytyramine, serotonin, GABA, glutamate, acetylcholine, and L-alpha-glycerylphosphorylcholine, in histological tissue sections at high spatial resolutions. The method is employed to directly measure changes in the absolute and relative levels of neurotransmitters in specific brain structures in animal disease models and in response to drug treatments, demonstrating the power of mass spectrometry imaging in neuroscience.
INTRODUCTION
Small-molecule neurotransmitters such as the catecholamine dopamine (DA), the amino acids g-amino butyric acid (GABA) and glutamate (Glu), and acetylcholine (ACh) are critical chemical messengers that transmit signals between neurons. Changes in their concentrations are associated with numerous normal neuronal processes, such as sleep and aging, but also several disease states, including Alzheimer's disease, Parkinson's disease (PD), depression, drug addiction, and attention deficit hyperactivity disorder. A better understanding of their relative abundance and distribution would provide insights into these complex neurological processes and disorders. At present, researchers rely on indirect histochemical, immunohistochemical (IHC), and ligand-based assays to detect these small-molecule transmitter substances (de Jong et al., 2005; Falck et al., 1962; Jones and Beaudet, 1987) . The antibodies used in IHC often have major limitations, such as an inability to distinguish between different transmitters (Keenan and Koopowitz, 1981) .
Nuclear medicine imaging is a widely used tool for indirect visualization of the distribution, abundance, and activity of neurotransmitters in the brain, relying on radiolabeled tracers that emit gamma rays, which are detected using positron emission tomography (PET) or single photon emission computed tomography scanners (Pimlott and Sutherland, 2011) . Developing appropriate labeled compounds is often complicated, particularly for studying endogenous chemical messengers (Badgaiyan, 2011) . There is often an inability to discriminate between the labeled parent compound and a metabolite retaining the label. Imaging techniques that can directly visualize the localization of neurotransmitters and simultaneously quantitate them without relying on a label would thus represent a scientific breakthrough. Another significant advance in the molecular analysis of neurological tissues would be the development of a multiplex method that enables the simultaneous detection of multiple endogenous compounds and pharmaceutical agents.
MALDI mass spectrometry (MS) imaging has been used for direct molecule-specific compound detection, distribution mapping, and identifying molecular species in tissue sections (Caprioli et al., 1997; Cornett et al., 2007) . It can generate multiplex full mass spectrum data at near-cellular spatial resolution. Crucially, it provides a powerful tool for in situ visualization of target compounds and for determining their abundance and spatial distribution without requiring a great deal of a priori information. Moreover, the data gathered during such experiments can be used to simultaneously identify unknown endogenous molecular changes due to disease or degeneration. MALDI-MS can be used for the direct analysis of targets, ranging from small molecules to large proteins (Schwamborn and Caprioli, 2010) . However, despite some notable successes, it is relatively insensitive toward certain compound classes and sometimes suffers from signal interference caused by matrix clusters/fragments (Sugiura et al., 2012; Ye et al., 2013) . To date, it has found only limited applications in the study of neurotransmitters due to their poor ionization efficiencies. As such, the development of a reagent that would enable selective neurotransmitter derivatization while also facilitating their detection by MS and acting as an efficient matrix to assist their laser-induced desorption and ionization would be a significant breakthrough.
Here we describe a unique approach for the direct and absolute quantitative imaging of classical and common neurotransmitters in histological brain tissue sections. We report an example of the simultaneous mapping of biogenic amines and amino acid chemical messengers following in situ derivatization in brain tissue sections. The method is employed to simultaneously measure changes in the levels of neurotransmitters, including tyrosine, tryptamine, tyramine, phenethylamine, DA, 3-methoxytyramine (3-MT), serotonin (5-HT), GABA, and Glu, in specific brain structures of primates and rodents with and without DA depletion and L-3,4-dihydroxyphenylalanine (L-DOPA) treatment. In addition, we have developed a method that can be used to image and quantitate ACh and an ACh precursor, L-alpha-glycerylphosphoryl-choline (alpha-GPC) in brain sections, as well as to study activity within cholinergic pathways by measuring changes in ACh concentrations, imaged at a 15 mm spatial resolution. Together, these experiments demonstrate a significant advancement in the molecular imaging arsenal available to neuroscientists.
RESULTS AND DISCUSSION
Without modification, most neurotransmitters are not directly detectable by MALDI-MS due to their poor ionization efficiency and the overlapping signals of isobaric compounds. To address the limited ionization and desorption of neurotransmitters, we developed a method for their in situ chemical derivatization. Once modified, the neurotransmitters are readily ionized and detected, enabling their identification and the quantitative mapping of their distributions. Our strategy uses pyrylium salts such as 2,4-diphenyl-pyranylium tetrafluoroborate (DPP-TFB), which react selectively with primary amines to produce N-alkyl-or N-aryl-pyridinium derivatives ( Figure S1 , available online). The reaction proceeds under very mild conditions and occurs rapidly at ambient temperature and pressure without any need for stirring or agitation. Such conditions are required to preserve the localization of endogenous compounds. The resulting charged derivatives have laser desorption and ionization efficiencies sufficient to enable the detection of endogenous small-molecule primary amines (Johannesen et al., 2012; Quirke et al., 1994) , such as tyrosine, tryptamine, tyramine, phenethylamine, DA, 3-MT, 5-HT, GABA, and Glu, simultaneously in a single experiment. Importantly, the selective derivatization of the primary amines separates their signals from those of overlapping isobaric compounds. A MALDI-MS analysis of a representative pyrylium derivatization reaction clearly showed that all of the desired pyridinium ions were formed in high yields ( Figure S1 ). Furthermore, the DPP-TFB derivatives of endogenous primary amines, including neurotransmitters and their metabolites and precursors, undergo self-assisted laser desorption ionization. As such, they are amenable to MALDI-MS imaging without needing to be assisted by a matrix such as a-cyano-4-hydroxycinnamic acid (CHCA).
The combination of pyrylium derivatization and multiplex data acquisition generates hundreds of ion signals in each MALDI-MS imaging experiment. This makes it possible to obtain images showing the distribution of every individual ion within an m/z window of 200 to 450 in the sample being studied ( Figure 1A ).
In addition to showing the distributions of known derivatives, these images can be used to characterize unidentified ions whose concentrations and localizations may be affected by neurological events and diseases. We demonstrated this by determining the localization of selected neurotransmitters in brain tissue samples derivatized using DPP-TFB and also 2,4,6-trimethyl-pyranylium tetrafluoroborate (TMP-TFB) as a confirmatory reagent. The identities of the signals for the neurotransmitter derivatives were verified by performing tandem MS (MS/MS) experiments using derivatized synthetic standards alongside the endogenous neurotransmitter. In all cases, the product ions observed for the standards were identical to those for the endogenous species. For example, both exogenous and standard GABA generated a peak at m/z 208.1 and similar MS/ MS product ions when derivatized with TMP-TFB and m/z 318.1 and similar MS/MS product ions when derivatized with DPP-TFB ( Figure S1 ). Similarly, both endogenous and standard DA yielded peaks at m/z 136 and m/z 232, respectively, after derivatization with these reagents ( Figure S1 ). In addition, the elemental compositions obtained for the target ions from accurate mass Fourier transform ion cyclotron resonance (FT-ICR)-MS measurements were in good agreement with the expected structures of the derivatized neurotransmitters (Tables S1 and  S2 ). Deuterated neurotransmitters were used as calibration standards to determine the absolute concentrations of the endogenous neurotransmitters directly in brain tissue sections.
MALDI-MS Imaging of Neurotransmitters in Control Rodent Brain Sections
The in situ neurotransmitter derivatization and imaging procedure was initially demonstrated using coronal and sagittal mouse and rat brain sections (Figures 1, S1 , and S2). The distribution of the pyrylium salt formed by derivatizing GABA with DPP-TFB (m/z 318.1) in coronal rat brain tissue sections showed that GABA is most abundant in the medial septum/diagonal band region (MSDB) of the brain ( Figure S2 ), which is consistent with previous reports (Alreja et al., 2000) . The MSDB provides a major GABAergic input to the hippocampus (Alreja et al., 2000; Qin and Luo, 2009 ). Imaging of sagittal rat brain sections (Figure 1B) revealed structures with high GABA concentrations, including the hypothalamus, midbrain, and basal forebrain (Figure 1C) . GABA is a dominant neurotransmitter in the hypothalamus and plays an important role in hypothalamic inhibitory circuits (Decavel and Van den Pol, 1990) . Moreover, the basal forebrain and its substructures are reported to provide major GABAergic inputs to the hippocampus (Alreja et al., 2000) . The importance of midbrain neurons in GABA recycling and the corelease of GABA from the dopaminergic midbrain neurons via plasma membrane uptake (Tritsch et al., 2014) may explain the high GABA concentration in this region. Deuterated GABA (D 6 -GABA) was used to determine absolute GABA concentrations in rat brain tissue sections. The absolute concentration of GABA in the coronal brain section as a whole was 5 nmol/mg, while that in the MSDB region was 10 nmol/mg ( Figure S2 ). These values are consistent with previous results (Schaaf et al., 1985) .
Other primary amine neurotransmitters, such as tyrosine, tryptamine, tyramine, phenethylamine, DA, 3-MT, 5-HT, GABA, and Glu, were detected and imaged in the same brain tissue sections that were treated with DPP-TFB to produce 2,4-diphenylpyridinium derivatives. As before, this substantially increased the neurotransmitter's MALDI desorption/ionization efficiency and generated a detectable signal at m/z 362.1 ( Figure S1 ). Glu was found in most structures of the brain but was mainly localized in the striatal and cortex regions ( Figure S2 ), which is consistent with previous reports on the distribution of Glu transporters (Bressan and Pilowsky, 2000; El Mestikawy et al., 2011; Herzog et al., 2004) . The identity of the Glu peak was verified by MS/MS fragmentation of derivatized synthetic standards (deuterated and nondeuterated) and the endogenous signal ( Figure S1 ).
Analyses of rat brain sagittal sections revealed high DA concentrations in the substantia nigra, striatum, and ventral pallidum structures due to the nigrostriatal and mesolimbic DAergic pathways ( Figure 1D ). 3-MT, a methylated DA metabolite formed by the action of the enzyme catechol-O-methyl transferase, was also imaged and found to have the same distribution as DA ( Figure 1E ). 3-MT was initially reported to be an inactive DA metabolite, but recent studies suggest that it is a neuromodulator that acts as an agonist of the trace amine-associated receptor 1 (Sotnikova et al., 2010) . It is worth noting that distinguishing between an endogenous compound and its metabolites is very difficult when using techniques based on radiolabeled compounds. In the coronal sections ( Figure 1F ), DA was mostly localized in the striatal regions ( Figure 1G ), but it was also present at lower concentrations in the cingulate cortex, piriform cortex, medial septal nucleus, and the nucleus of the vertical limb of the diagonal band ( Figure 1H ). The intensities of the DA signals for selected regions ( Figure 1F ) were used to quantify their DA levels in relative terms ( Figure 1I ), revealing that the average DA concentration in the striatal region is about 40 times higher than that in the cingulate cortex region.
Neurotransmitter MALDI-MS Imaging of Parkinson's Disease Models
To further demonstrate the potential of the derivatization/MALDI-MS imaging methodology, it was used to analyze the distribution A sagittal tissue section from a rat brain (B) and the associated relative abundances and distributions of GABA (C), DA (D), and 3-MT (E). GABA was found in all structures of the brain but was most abundant in HY, BF and its substructures, and MB. High DA concentrations were observed in SN, CP, VS, and AON. The distribution of 3-MT mirrored that of DA. DA imaging in a rat brain coronal tissue section (F) revealed that it was most abundant in the striatal region (G). By rescaling the signal intensity of the latter image, it was possible to detect DA in other parts of the brain, notably in the A24, Pir, MS, and VDB. However, the DA concentrations in these substructures were all much lower than that in striatal region (H). The intensities of the DA signals in each region of the brain were compared to enable its relative quantitation. The inset bars show the rescaled DA signal intensities for the Pir, MS and VDB, and A24 regions (I). MS data were acquired using either a MALDI-TOF/TOF (A-E) or a MALDI-FT-ICR mass spectrometer (G-I). Data are shown using a rainbow scale, normalized against the total ion count. Scale bar, 2 and 5 mm. Images were acquired at spatial resolutions of 100 mm for sagittal sections and 150 mm for coronal sections. Substantia nigra, SN; caudate-putamen, CP; ventral striatum, STRv; anterior olfactory nucleus, AON; cingulate cortex (area 24), A24; piriform cortex, Pir; medial septal nucleus, MS; nucleus of the vertical limb of the diagonal band, VDB; accumbens nucleus, ACB; hypothalamus, HY; thalamus, TH; hippocampus, HIPP; corpus callosum, cc; cerebral cortex, CTX; midbrain, MB; basal forebrain, BF. See also Figure S1 .
of neurotransmitters in experimental models of PD. When studying neurodegeneration processes in PD models, it is desirable to assess the integrity and function of the nigrostriatal DAergic pathway. Various techniques have been used for this purpose, including the quantitation of dopaminergic neurons and terminals in the substantia nigra pars compacta and striatum by immunostaining using an antibody against tyrosine hydroxylase (TH), and the measurement of TH or DA transporters (DAT) in striatal tissue extracts by immunoblotting (Ciliax et al., 1995; Huot et al., 2007) . Alternatively, the dopamine neurons can be quantified by using autoradiography to measure the levels of a radiolabeled DAT ligand (Boja et al., 1991) . The best way to quantitate DA is to use high-performance liquid chromatography coupled with an electrochemical detector. However, this approach provides no information on the neurotransmitter's anatomical localization. Dopaminergic terminals are heterogeneously distributed in the striatum; in PD, it is mainly the dorsolateral regions that exhibit reduced DA levels. Important information might therefore be lost if the anatomical distribution of DA is not determined. Our method allows the simultaneous direct imaging and quantitation of primary amine neurotransmitters in tissue sections from animal models of PD.
The PD models used in our experiments were generated by injecting the neurotoxin 6-hydroxydopamine (6-OHDA) into rodents' medial forebrain bundles (Zhang et al., 2008) or by intravenous administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to primates. Pyrylium derivatization and MALDI-MS imaging were then used to quantify neurotransmitter levels in rat brain sections by depositing known concentrations of deuterated standards onto vehicle control tissue sections. The DA concentrations in the intact and 6-OHDAlesioned sides of rat striata were determined to be 124 pmol/mg Distribution of GABA (P-R) is imaged in shamlesioned (P), 6-OHDA-lesioned (Q), and 6-OHDAlesioned L-DOPA-treated animals (R), and tyrosine is imaged in sham-lesioned (S), 6-OHDA-lesioned (T), and 6-OHDA-lesioned L-DOPA-treated animals (U). There are clear differences in the concentrations of the studied amines in different regions of the brain and between treatments. MS images were acquired using a MALDI-FT-ICR mass spectrometer. Data are shown using a rainbow scale, normalized against the total ion count. Scale bar, 2 mm; spatial resolution = 150 mm. See also Figure S2 . and 84 pmol/mg, respectively ( Figure S2) ; these values are consistent with previous results obtained by HPLC (Zhao and Suo, 2008) .
Pyrylium derivatization and MS imaging were used to evaluate the neurochemical changes that occur in 6-OHDA PD models with and without L-3,4-dihydroxyphenylalanine (L-DOPA) treatment. Some of the model animals were treated with deuterated L-DOPA (D 3 -L-DOPA), which is converted into deuterated dopamine (D 3 -DA) in vivo. The derivatization/MALDI-MS imaging protocol successfully distinguished endogenous DA from both the administered D 3 -L-DOPA and D 3 -DA. Sham-lesioned rat brain tissue sections had a normal DA distribution in their striatal regions, but the intensity of the DA signal was significantly lower in the lesioned side of the brain, with or without D 3 -L-DOPA treatment (Figures 2A-2C ). The distributions of DA in the lesioned side of the brain and structures with low DA levels, such as the cortex, were determined by rescaling the intensities of the MS-derived images ( Figures 2D-2F ).
No interfering signal for D 3 -DA was detected in sham-or 6-OHDA-lesioned brain tissue sections (Figures 2G and 2H) , and the signal corresponding to D 3 -DA (derived from D 3 -L-DOPA) was only observed in the nonlesioned sides of brains treated with D 3 -L-DOPA ( Figure 2I ). This is presumably due to the destruction of dopaminergic neurons, which are essential for the uptake and conversion of L-DOPA to DA. The distribution images for 3-MT showed that its concentration was high in the intact sides of the brain but lower in the lesioned sides ( Figures 2J-2L) . The average concentration of 3-MT in the nonlesioned sides of 6-OHDA-treated brains ( Figures 2K and 2L ) was higher than that in sham-lesioned brains ( Figure 2J ). The metabolic conversion of D 3 -L-DOPA to D 3 -3-MT was traced by measuring the concentration of D 3 -3-MT, which was highest in the nonlesioned side of the brain ( Figure 2O ); no interfering signal was detected in untreated brains ( Figures 2M and 2N ). This experiment also showed that D 3 -L-DOPA treatment increased striatal GABA levels in the lesioned side of the brain ( Figure 2R ) relative to those in sham-and 6-OHDA-lesioned brain sections ( Figures 2P and 2Q, respectively) . Changes in GABAergic signaling throughout the basal ganglia (including the striatum and the substantia nigra pars reticulate) after the destruction of dopaminergic neurons and L-DOPA treatment have been extensively documented (Galeffi et al., 2003; Wang et al., 2007) . Tyrosine is the biosynthetic precursor of the catecholamines and exhibited the same distribution as 3-MT and DA (Figures 2S-2U) .
Accurate mass FT-ICR-MS imaging was also performed on selected regions of coronal brain sections, including the caudate and putamen, of control and MPTP-lesioned primates ( Figures  3A and 3B ). The measured m/z values for selected neurotransmitters matched the corresponding theoretical values with sub-ppm deviations (Table S2) . DA ( Figure 3C ) and 3-MT (Figure 3E) were localized in the caudate and putamen regions of the brain. However, the concentrations of DA ( Figure 3D ) and 3-MT ( Figure 3F ) in the MPTP-lesioned brain sections were around 30 and 100 times lower, respectively, than that in the controls ( Figure S3 ).
Several reports have discussed the varied roles of 5-HT in PD (Fox et al., 2009) . By reanalyzing the data from the experiments used to study the distribution of DA and the effects of L-DOPA in PD models, we were able to map the distribution of 5-HT in control ( Figure 3G ) and MPTP-lesioned ( Figure 3H ) brain tissue sections. 5-HT was localized to the nucleus basalis (Meynert), the hypothalamic regions, and the substantia nigra. MPTP lesioning increased its concentration in these regions by >40% ( Figure S3 ). Increases in 5-HT concentrations following MPTP-induced DA denervation have previously been demonstrated by in vivo microdialysis; it was suggested that they are due to the brain's compensatory processes and recovery mechanisms (Boulet et al., 2008) .
Increased levels of striatal GABA have been reported in humans with PD, 6-OHDA-treated rats, and MPTP-treated primates. Striatal GABA levels increased by 70% in MPTP-lesioned brains ( Figures 3I, 3J , and S3) (Boulet et al., 2008) ; interestingly, its concentration also rose in the hypothalamic regions. In addition to DA, 5-HT, and GABA, high mass accuracy FT-ICR imaging maps were also generated for phenethylamine, tyramine, and tryptamine (Table S2 ) in control and MPTP-treated primate brains ( Figure S3 ).
It is important to recall that while the derivatization/MALDI-MS imaging technique makes it possible to simultaneously determine the distributions of multiple known species by interrogating the data set from a single experiment in a targeted manner, it can also provide information on as-yet unidentified molecular species.
ACh Imaging and Analysis of the Distribution of Cholinergic Neurons Using a Deuterated MALDI Matrix
While pyrylium derivatization provides a powerful tool for studying primary amine neurotransmitters, some important neurotransmitters, such as ACh and alpha-GPC do not contain primary amines and so do not react with pyrylium cations. We therefore developed an alternative method for their imaging. MALDI-MS analysis generally requires the homogeneous application of a matrix to the sample surface to facilitate the laser desorption ionization process. One of the most widely used matrices for MALDI-MS imaging of small molecules is CHCA. Unfortunately, all matrices generate numerous readily detected fragments and cluster ions in the low molecular weight region of the mass spectrum, which can mask signals from target analytes such as ACh (m/z 146.1). One way of avoiding such target mass interference is to use a deuterated CHCA (D 4 -CHCA) matrix , which shifts the interfering signals by a minimum of 4 m/z units. This method was used to facilitate the imaging of molecular ACh and alpha-GPC (m/z 258.1) and thereby monitor changes in their abundance in different parts of the brain during neurological events that affect the cholinergic system. ACh and alpha-GPC were identified by MS/MS fragmentation ( Figure S4 ).
Cholinergic neurons are anatomically ubiquitous. However, it has been difficult to study their distribution in the CNS based on the presence of ACh because of difficulties in detecting and quantifying ACh in situ. Instead, cholinergic neuron distributions have been studied by examining markers such as acetylcholinesterase (the enzyme that degrades ACh), muscarinic and nicotinic ACh receptors, and choline acetyltransferase (the enzyme that catalyzes ACh synthesis). By using a deuterated CHCA Neuron Quantitative Molecular Imaging of Neurotransmitters matrix, we were able to directly investigate the cholinergic neuron distribution in the brain based on the concentrations of ACh in its various regions ( Figure 4A ). Imaging of rodent sagittal sections taken from different levels of the brain revealed high ACh concentrations in the frontal cortex, olfactory bulb, striatum, hippocampus, medial habenula, tectum, thalamus, ventral tegmental area, interpeduncular nucleus, pedunculopontine tegmental nucleus, and the laterodorsal tegmental nucleus. This is consistent with previous findings (Hammond et al., 1994) .
High-Resolution MALDI-MS Imaging of ACh
High spatial resolution MALDI-MS imaging makes it possible to map the distributions of neurotransmitters within substructures of the brain with high spatial resolution. Using our methodology, we determined the relative abundance of ACh in various substructures of the hippocampus, cerebellum, and striatum at a spatial resolution of 15 mm (Figures 4C-4E ). The concentration of ACh was greater in the gray matter of cerebellum than in the white matter ( Figure 4E ). Certain subregions of the hippocampus . MALDI-FT-ICR imaging of DA (C) and 3-MT (E) in control brains showed that these compounds are most abundant in the caudate and putamen structures. Conversely, both DA (D) and 3-MT (F) are almost absent in these regions after the destruction of their dopaminergic neurons by MPTP-lesioning. 5-HT is mostly localized in the nucleus basalis (Meynert) of the brains, and its concentration is significantly lower in control brains (G) than in MPTP-lesioned tissue sections (H). The 5-HT-rich hypothalamic structure was also imaged in control and MPTP-lesioned brain sections, revealing that lesioning increased its 5-HT concentration. The concentrations of GABA in the putamen and caudate were significantly higher in the MPTPlesioned brain (J) than the control (I). All MS images were acquired using a MALDI-FT-ICR mass spectrometer. Data are shown using a rainbow scale over a single range, normalized against the total ion count. Scale bar, 10 mm; spatial resolution = 200 mm. Caudate, cd; putamen, Put. See also Figure S3 .
were also enriched in ACh, notably the granule cell layer of the dentate gyrus (DG-sg) and the pyramidal layer (sp) of CA1 (Ammon's horn) ( Figures 4C and  4F ). These subregions of the hippocampus are delineated in Figure 4B , which shows a MALDI-MS image generated using data for a lipid with an m/z value of 721.2.
The power of high spatial resolution MS imaging was further demonstrated by studying the distribution of ACh in the basal ganglia of the brain. In the striatum, ACh serves as the transmitter of the large aspiny interneurons, which have diameters of 20-60 mm (Kawaguchi, 1992) and comprise 1%-2% of the total striatal cell population (Aosaki et al., 1998) . While the cell bodies of the cholinergic interneurons are relatively few in number, they densely innervate the striatum with their extensive axonal arborizations (Holt et al., 2005) . As shown in Figure 4D , the striatal ACh concentrations can be measured by MALDI-MS imaging with a spatial resolution of 15 mm.
It is anticipated that the continuing development of MALDI-MS imaging technologies will improve to a point that enables the analysis of small sample areas of tissue sections at subcellular resolution. Recently, it was demonstrated that MALDI-MS instrumentation capable of imaging at resolutions < 1 mm is technically feasible (Zavalin et al., 2012) . Therefore, imaging neurotransmitters at subcellular spatial resolution in the near future would lead to further biological insights and make the method even more compelling.
Neuron Quantitative Molecular Imaging of Neurotransmitters
Imaging of ACh and Alpha-GPC in Brain Sections of Tacrine-Administered Rodents As a final illustration of the power of the deuterated matrix technique, it was used to investigate the distributions of ACh ( Figures  5A and 5B) and alpha-GPC ( Figures 5C and 5D ) in sagittal sections of mouse brains from animals that had been treated with 10 mg/kg intraperitoneal tacrine (a centrally acting cholinesterase inhibitor) and untreated control animals. The concentration of ACh in the tacrine-treated brains was approximately seven times greater than that in the control brains, and the concentrations of alpha-GPC within brain structures decreased as their ACh levels increased. In both the control ( Figure 5A ) and tacrine-treated ( Figure 5B) brain sections, the ACh concentration was determined for selected brain structures using a standard calibration curve created by spotting known quantities of deuterated ACh (D 9 -ACh) onto consecutive control brain tissue sections ( Figure S5 ). Absolute quantities of ACh ( Figure 5E ) and relative concentrations of alpha-GPC ( Figure 5F ) were determined for the whole brain, hippocampus, caudate putamen, thalamus, and cerebral cortex regions in both control and tacrine-treated brains. The average measured concentration of ACh was consistent with previous results (Stavinoha and Weintraub, 1974) .
Conclusions
The methods presented herein represent powerful tools for the quantitative imaging of neurotransmitters, including biogenic amines, amino acids, and ACh in histological brain tissue sections. Pyrylium derivatization and deuterated CHCA matrices extend the reach of MALDI-MS imaging, a technique with excellent mass accuracy and resolving power, allowing it to be used in the characterization of compounds that were previously problematic. Pyrylium derivatization converts low molecular weight endogenous primary amines into readily ionized species of relatively high molecular weight. This makes it possible to simultaneously image tyrosine, tryptamine, tyramine, phenethylamine, DA, 3-MT, 5-HT, GABA, and Glu and other endogenous primary amines in a single MALDI-MS experiment. The use of a deuterated matrix allows one to sidestep problems caused by the masking effect of matrix-derived ions in MALDI-MS analyses of low molecular weight species, such as ACh, that lack a primary amine group. Because MALDI-MS imaging can be performed at a spatial resolution as low as 15 mm, these technologies make it possible to measure the distributions of a wide range of neurotransmitters with high spatial resolution. The concentrations of neurotransmitters in different subregions of the brain were quantified by comparing the intensities of their signals to those generated by known quantities of deuterated calibration standards. The techniques presented herein permit the simultaneous quantitation and specific molecular imaging of multiple neurotransmitters in situ. As such, they should find diverse and immediate applications in fields such as neuroscience, pharmacology, drug discovery, neurochemistry, and pathology.
EXPERIMENTAL PROCEDURES
All chemicals and reagents were purchased from Sigma-Aldrich unless otherwise stated and were used without further purification. Ketamine was obtained , and CB (E) were determined by high-resolution imaging. The concentration of ACh in the gray matter of CB is around five times greater than that in the white matter. In the HIPP, high ACh concentrations are apparent in DG-sg and sp regions (F). MS images were acquired using a MALDI-TOF/TOF mass spectrometer. Data are shown using a rainbow scale and are normalized against the total ion counts; scale bars, 2 mm, 1 mm, and 500 mm; spatial resolutions = 100 mm and 15 mm. Caudate-putamen, CP; hippocampus, HIPP; cerebellum, CB; granule cell layer of the dentate gyrus, DG-sg; pyramidal layer of CA1, sp; cerebral cortex, CTX; piriform area, PIR; striatum (ventral region), STRv; thalamus, TH; subiculum, SUB; stratum lacunosum-moleculare, Slm; stratum radiatum, Sr; stratum oriens, So; cornu ammonis (field 2), CA2; cornu ammonis (field 3), CA3; polymorph layer of dentate gyrus, PO. See also Figure S4 . 
Animal Experiments
Male Sprague-Dawley rats (approximately 150 g; Scanbur) and C57BL/6J male mice (3 months old, Charles River Laboratories) were housed in separate air-conditioned rooms (with a 12 hr dark/light cycle) at 20 C and a humidity of 53%. Experiments were performed in agreement with the European Communities Council Directive of November 24, 1986 (86/609/EEC) on the ethical use of animals and were approved by the local ethical committee at the Karolinska Institute (N350/08). Unilateral 6-OHDA lesioning of nigral dopaminergic axons was performed as described previously (Zhang et al., 2008) . Briefly, rats were anesthetized with ketamine (80 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and pretreated with desipramine (25 mg/kg, i.p.) and pargyline (5 mg/kg, i.p.). They were placed in a stereotaxic instrument and injected with 6-OHDA (2.5 ml of a 5 mg/ml solution) in the medial forebrain bundle (MFB) of the right hemisphere (AP = À2.8 mm, ML = À2.0 mm, and V = À9.0 mm).
To determine the success of nigrostriatal denervation following unilateral 6-OHDA lesioning, a single injection of apomorphine (1 mg/kg, i.p.) was administered to the rodents 2 weeks after their treatment with 6-OHDA, and their resulting contralateral rotations were measured over 30 min. Only rats that performed more than 100 turns were used in subsequent studies. They were killed by decapitation 4 weeks after the surgery, after which their brains were removed, frozen in dry ice-cooled isopentane, and stored at À80 C until needed. (E and F) Bar graphs showing the absolute concentration of ACh (E) and relative concentration of alpha-GPC (F) with (black bars) and without (white bars) administration of tacrine in whole brains and selected structures. MS images were acquired using a MALDI-TOF/TOF mass spectrometer. Data are shown using a rainbow scale over a single range, normalized against the total ion count. Scale bar, 2 mm; spatial resolution = 100 mm. Caudateputamen, CP; hippocampus, HIPP; cerebral cortex, CTX; thalamus, TH. See also Figure S5 .
For D 3 -L-DOPA treatment experiments, 4 weeks after the surgery, rats were treated with L-DOPA (10 mg/kg, i.p.) and benserazide (7.5 mg/kg, i.p.) once daily for 3 weeks. Animals were sacrificed by decapitation 30 min after the last i.p. injection, which was deuterated (D 3 )-L-DOPA (10 mg/kg) and benserazide (7.5 mg/kg). Handling and storing the brains was performed as described above. Primate experiments were conducted using tissue from a previously published brain bank (Fernagut et al., 2010; Porras et al., 2012; Santini et al., 2010) . Experiments were carried out in accordance with European Communities Council Directive of November 24, 1986 (86/609/EEC) for care of laboratory animals in an AAALAC-accredited facility following acceptance of study design by the Institute of Lab Animal Science (Chinese Academy of Science, Beijing, China) IACUC. Briefly, two female rhesus monkeys (Macaca mulatta, Xierxing; mean age = 5 ± 1 years; mean weight = 5.3 ± 0.8 kg) were used. One animal was kept untreated as control. The other animal received daily MPTP (0.2 mg/kg, i.v.) according to previously published protocol (Bezard et al., 1997 (Bezard et al., , 2001a (Bezard et al., , 2001b . Following stabilization of the MPTP-induced syndrome, animal behavior was assessed as previously published (Ahmed et al., 2010; Fasano et al., 2010; Fernagut et al., 2010; Muñ oz et al., 2008; Porras et al., 2012) . The degree of parkinsonism was assessed using a validated macaque clinical scale (Imbert et al., 2000) . Animals were killed by sodium pentobarbital overdose (150 mg/kg, i.v.) , and brains were removed quickly after death and immediately frozen by immersion in isopentane (À45 C) and stored at À80 C.
For the ACh experiments, mice that were 3 months old were injected with saline or tacrine (10 mg/kg i.p.) and then sacrificed after 30 min according to the procedure described above.
Tissue Section Preparation
The frozen brain tissues were cut using a cryostat-microtome (Leica CM3050S, Leica Microsystems). Sagittal and coronal brain sections were cut at a thickness of 14 mm. Tissue sections were transferred by thaw mounting onto conductive indium tin oxide (ITO) glass slides (Bruker Daltonics) and then stored at À80
C. Sections were desiccated at room temperature for 15 min prior to spotting of calibration standards, after which they were imaged optically using a photo scanner (Epson perfection V500). The samples were then coated with matrix for ACh experiments or derivatized with or without matrix coating for primary amine imaging experiments. To enable the quantitation of individual neurotransmitters, deuterated ACh, DA, or GABA dissolved in 50% methanol was spotted onto the control tissue sections to serve as calibration standards prior to derivatization and matrix application.
Derivatization of Calibration Standards and Endogenous
Primary Amines DPP-TFB and TMP-TFB were dissolved in methanol to prepare 1 mg/ml stock solutions. Derivatization was performed using solutions containing 150 ml of the stock solution of DPP-TFB or TMP-TFB in 1.5 ml of 50% methanol, buffered by 1 ml triethylamine (TEA). The derivatization solution was applied to the tissue sections using an automatic sprayer (ImagePrep, Bruker Daltonics). To facilitate the derivatization reaction and to avoid delocalization of the endogenous compounds, reagents were added using a three-step process involving spraying, incubation, and drying, which lasted for 2.5, 15, and 50 s, respectively. The prepared slides were then incubated for 60 min in a chamber saturated with the vapor arising from a 50% methanol solution. To acidify the tissue sections, 1 ml of a solution containing acetic acid, water, and methanol (10:45:45) was sprayed over the tissue using the same setup as above. The treated tissue sections were then incubated once more in the methanol vapor-saturated chamber for 30 min. Primate and D 3 -L-DOPA-treated rat tissue sections were analyzed using a high concentration of DPP-TFB as reactive matrix. DPP-TFB was dissolved in 1.2 ml of methanol to prepare 8 mg/ml of the stock solution. This solution was diluted in 6 ml of 70% methanol containing 3.5 ml of TEA. An automated pneumatic sprayer (TM-Sprayer, HTX Technologies) was used to spray warm reagent over the dried samples. The nozzle temperature was set at 80 C, and the reagent was sprayed (30 passes) over the tissue sections at a linear velocity of 110 cm/min with a flow rate of about 80 ml/min. Samples were then incubated for 15 min (dried by nitrogen flow every 5 min) in a chamber saturated with the vapor arising from a 50% methanol solution. Stock solutions of DPP-TFB and TMP-TFB (2 mg/ml in methanol) and standards of DA, GABA, and Glu (1 mg/ml in methanol) were used for in-solution derivatization experiments. Stock solutions of neurotransmitters (2 ml) and derivatization reagents (10 ml) were added to the solvent containing 90 ml of 50% methanol, buffered by 0.1 ml TEA. The mixture was incubated for 30 min at room temperature, followed by addition of 1 ml of acetic acid. Samples were spotted (0.5 ml) to dry on stainless steel plates.
Matrix Coating and MALDI-MS Imaging Data Acquisition CHCA (0.5 ml of 10 mg/ml in 50% ACN, 0.2% TFA) was spotted over dried derivatized neurotransmitters on stainless steel plates. D 4 -CHCA was prepared as reported previously . The MALDI-MS matrix was applied to the tissue sections as follows. A 10 ml solution of 10 mg/ml CHCA (for analysis of tissues with low concentration of derivatization reagent) or D 4 -CHCA (for analysis of ACh) in 50% ACN containing 0.2% TFA was sprayed onto the tissues sections using a TLC sprayer. The sprayer was maintained at a distance of 30 cm from the target during matrix coating, and sections were allowed to dry between coating cycles. For high spatial resolution (HSR) MALDI-MS imaging of ACh and low spatial resolution (LSR) matrix-assisted imaging experiments, D 4 -CHCA and CHCA (5 mg/ml dissolved in 50% ACN containing 0.2% TFA) were applied using an automatic sprayer (TM-Sprayer, HTX Technologies). All parameters were optimized in order to reach the best sensitivity and minimize delocalization of target compounds. The nozzle temperature was set at 98 C (for HSR experiments) and 90 C (for LSR experiments). The matrix was sprayed (eight passes for HSR and six passes for LSR experiments) over the tissue sections at a linear velocity of 110 cm/min with a flow rate of about 70 ml/min. The quantity of matrix solution applied in this way was measured using an optical sensor present in the automatic sprayer (ImagePrep, Bruker Daltonics) to ensure that the same amount of matrix was applied to each slide. All MALDI-MS imaging experiments were performed using either MALDI-TOF/ TOF (Ultraflextreme, Bruker Daltonics) or MALDI-FT-ICR (Solarix XR 12T, Bruker Daltonics) mass spectrometer in positive ion mode using a Smartbeam II 2 kHz laser. The mass spectrometer's operating parameters were set according to the manufacturer's recommendations for optimal acquisition performance. The laser spot size was selected to yield intermediate and sharp levels of focus ($40 mm and 10 mm laser spot diameters) for low and high spatial resolution analyses. The laser power was optimized at the start of each run and then held constant during the MALDI-MS imaging experiment. On-tissue and on-plate MS/MS fragmentation experiments were performed in positive ion mode using the MALDI-TOF/TOF according to the manufacturer's recommended settings. Tissue sections were analyzed in a random order to prevent any possible bias due to factors such as matrix degradation or variation in mass spectrometer sensitivity. MS imaging data were visualized using FlexImaging (Bruker Daltonics), version 3.0 for TOF/TOF data and version 4.0 for FT-ICR data. Mass spectra analysis and chemical formula calculations were performed in Data Analysis, version 4.2 (Bruker Daltonics). An in-house-developed software package was used for data processing, normalization, and quantitation. Regions of interest were manually defined in the analysis software using both the optical image and MS imaging data (Kä llback et al., 2012) . The concentration of the target compounds in defined regions of interest were calculated by correlating their signal intensities to a calibration curve derived from deuterated analogs of the analytes spotted on control tissue sections considering the brain density as 1.0 g/cm 3 (Barber et al., 1970) .
Autoradiographic Studies
Sections that were used to study the distribution of DAT (a dopamine transporter) were preincubated in 50 mM Tris-HCl and 120 mM NaCl (pH 7.5) for 20 min and then incubated for 1 hr in the same buffer supplemented with 50 pM [ 125 I] RTI-55 in the presence of 1 mM fluoxetine (a selective serotonin reuptake inhibitor). The slides were washed twice for 10 s each in ice-cold binding buffer, rapidly dipped in deionized water, and dried. The sections were then exposed to Kodak BioMax MR films for 2 days.
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